Confidential mandate

Medtech Control-Tower Tender Architect

Planned Hiring / New

Medtech Control-Tower Tender Architect mandate in Basel, Switzerland · Medical Device Distribution

A medical-device group needs a buyer-side 4PL tender that converts fragmented shipment updates into intervention rights, event evidence and accepted patient-critical service outcomes across regions.

The mandate

Regional forwarders provide tracking portals, yet the buyer cannot reconstruct when custody, temperature, customs or delivery appointments changed, which party could intervene, or whether a reported delivery restored a surgical or diagnostic service. Procurement is preparing a 4PL tender around visibility and savings language. The defined problem is to specify an orchestrator contract whose events, authority and remedy are usable across implant, reagent and engineer-spares journeys without outsourcing manufacturer accountability.

The named deliverable is a Medtech Control-Tower Tender Architecture covering lane and consequence segmentation, event vocabulary, source and confidence, EPCIS-compatible critical tracking events where justified, exception detection, decision rights, escalation, alternate routing, quality hold, customs, inventory interface, patient-critical prioritisation, data custody, subcontractor transparency, charging, remedy, transition and exit. It includes requirements, evaluation cases, commercial schedules, operating playbooks and acceptance tests.

Five milestones govern six months. Week four reconstructs twelve failed journeys across four regions. Week nine concludes event, authority and buyer-retained accountability design. Week fourteen releases outcome-based requirements and an evaluation data room. Week nineteen runs four controlled bidder dialogues and scores responses against live cases. Week twenty-four delivers the accepted tender pack, negotiation positions, transition waves, exit controls, implementation cost and two simulated exception outcomes.

Acceptance rests with the chief supply chain officer and Sourcing Council; Quality, regulatory, trade and legal owners retain their judgments. Work is accepted only when shortlisted bidders can reconstruct unseen custody and exception chains, identify who may act within each clock, demonstrate subcontractor evidence, price comparable service units, return client data on exit and manage two patient-critical simulations without treating a portal notification as intervention or delivery scan as clinical availability.

The client provides de-identified shipment histories, carrier messages, temperature records, inventory states, hospital commitments, quality procedures, customs failures, contracts, invoices, data policies and bidder access. Consultants will not run the tender, select the winner, negotiate final terms, release product, direct live shipments or certify systems. Platform implementation, live provider transition and regulatory interpretation are excluded; specialist and buyer decisions remain attributable dependencies.

Why this is external work

Logistics, procurement, Quality and technology teams each describe a different control tower, and incumbent data structures shape the tender before the buyer has defined the service. Independent 4PL architecture can turn patient consequence and intervention into testable obligations. The assignment ends with an executable competition, not a preferred-provider recommendation or generic visibility dashboard.

What you will own

  • Reconstruct twelve medtech journeys across order, allocation, pack-out, custody, temperature, export, customs, delivery appointment and accepted receipt.
  • Segment lanes by product consequence, time tolerance, condition control, destination capability, customs exposure and recovery alternatives.
  • Define buyer, 4PL, carrier, broker, warehouse, Quality and account decision rights for every material exception clock.
  • Specify event meaning, source, confidence, correction, retention and portability, using EPCIS-compatible structures only where operationally useful.
  • Build bidder cases that test intervention, subcontractor control, patient-critical priority, degraded data and provider-exit behaviour.
  • Design comparable charging, service credit, cure, audit, step-in, transition and termination schedules tied to buyer outcomes.
  • Deliver the accepted requirements, evaluation rubric, commercial schedules, negotiation issues and phased transition architecture.

Candidate qualifications

  • Has designed or procured 4PL control-tower services for medtech, life science or another regulated critical-goods network.
  • Can evidence a tender outcome changed after tracking activity was separated from authorised intervention and accepted service restoration.
  • Understands shipment events, EPCIS concepts, condition control, trade compliance, subcontracting, inventory, data custody and logistics commercials.
  • Has built adversarial bidder cases without conducting procurement decisions or making regulated product-release judgments.
  • Can distinguish carrier scan, trusted event, material exception, authorised action, delivered package and usable clinical supply.
  • Has delivered tender packs whose acceptance, transition and exit provisions operated without continuing consultant interpretation.

Non-negotiables

  • Can complete twelve lane laboratories, four bidder dialogues and both exception simulations during six months.
  • Will not select bidders, negotiate final terms, release product, direct shipments or certify control-tower technology.
  • Brings direct buyer-side 4PL tender architecture; carrier sales or generic supply-chain digitisation alone is insufficient.
  • Will preserve missing, corrected, late and subcontractor-sourced events plus unsuccessful interventions in evaluation evidence.
  1. 49 words maximum. Which control-tower event looked visible but failed to support an authorised logistics intervention?
  2. 49 words maximum. How did you test a 4PL bidder’s control over unnamed subcontractors and data exit?
  3. 49 words maximum. Which medtech journey deserves patient-critical priority without distorting ordinary lane performance?

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.